Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Factor V Leiden as a risk factor for cirrhosis in chronic hepatitis C.

Literature DB >> 15057924

Factor V Leiden as a risk factor for cirrhosis in chronic hepatitis C.

Armelle Poujol-Robert, Pierre-Yves Boëlle, Raoul Poupon, Annie Robert.

Abstract

Entities: Disease

Mesh：

Substances：
factor V Leiden
Factor V

Year: 2004 PMID： 15057924 DOI： 10.1002/hep.20166

Source DB: PubMed Journal: Hepatology ISSN： 0270-9139 Impact factor: 17.425

Keyword Cloud
Cited

× No keyword cloud information.

10 in total

1. Association between ABO blood group and fibrosis severity in chronic hepatitis C infection.

Authors: Armelle Poujol-Robert; Pierre-Yves Boëlle; Dominique Wendum; Raoul Poupon; Annie Robert
Journal: Dig Dis Sci Date: 2006-08-22 Impact factor: 3.199

2. Increased fibrosis progression rates in hepatitis C patients carrying the prothrombin G20210A mutation.

Authors: Nitsan Maharshak; Philippe Halfon; Varda Deutsch; Hava Peretz; Shlomo Berliner; Sigal Fishman; Shira Zelber-Sagi; Uri Rozovski; Moshe Leshno; Ran Oren
Journal: World J Gastroenterol Date: 2011-12-07 Impact factor: 5.742

Review 3. Anticoagulation in Cirrhosis: Evidence for the Treatment of Portal Vein Thrombosis and Applications for Prophylactic Therapy.

Authors: Kylee Martens; Hannah S McMurry; Steven Koprowski; Justine Hum; Jessica Haraga; Janice H Jou; Joseph J Shatzel
Journal: J Clin Gastroenterol Date: 2022-04-29 Impact factor: 3.174

Factor V Leiden as a risk factor for cirrhosis in chronic hepatitis C.

1. Association between ABO blood group and fibrosis severity in chronic hepatitis C infection.

2. Increased fibrosis progression rates in hepatitis C patients carrying the prothrombin G20210A mutation.

Review 3. Anticoagulation in Cirrhosis: Evidence for the Treatment of Portal Vein Thrombosis and Applications for Prophylactic Therapy.

Review 4. What we should know about portal vein thrombosis in cirrhotic patients: a changing perspective.

Review 5. Thrombin activation and liver inflammation in advanced hepatitis C virus infection.

6. The association of non-O blood group and severity of liver fibrosis in patients with chronic hepatitis C infection.

7. Viral cirrhosis: an overview of haemostatic alterations and clinical consequences.

8. Thrombin and factor Xa link the coagulation system with liver fibrosis.

9. Hypercoagulability in End-stage Liver Disease: Review of Epidemiology, Etiology, and Management.

10. Thromboelastography does not predict outcome in different etiologies of cirrhosis.